Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “THE UNITED STATES OF AMERICA, as represented by th”

2,147 pharma patents match "THE UNITED STATES OF AMERICA, as represented by th" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,147
Index total 30,257
Page 58 / 90

Quick answer

This filtered view shows 2,147 pharmaceutical patents matching "THE UNITED STATES OF AMERICA, as represented by th" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,147 results for “THE UNITED STATES OF AMERICA, as represented by th” · 30,257 patents in full index Clear search

  1. US 8063195

    Mutations in a toll-like receptor motif in the NS4B of classical swine fever virus strain brescia influences virulence in swine

    The United States of America, as represented by the Secretary of Agriculture · Granted Nov 22, 2011 · Expires Nov 17, 2031

    granted

  2. US 8058248

    Foot and mouth disease virus vaccine comprising interferons

    The United States of America, as represented by the Secretary of Agriculture · Granted Nov 15, 2011 · Expires Nov 10, 2031

    granted

  3. US 8053422

    Anti-cancer oligodeoxynucleotides

    The United States of America, as represented by the Department of Health and Human Services · Granted Nov 8, 2011 · Expires Nov 3, 2031

    granted

  4. US 8053443

    N-substituted indenoisoquinolines and syntheses thereof

    The United States of America, as represented by the Department of Health and Human Services · Granted Nov 8, 2011 · Expires Nov 3, 2031

    granted

  5. US 8048427

    Subgenomic replicons of the flavivirus dengue

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 1, 2011 · Expires Oct 27, 2031

    granted

  6. US 8044189

    Bacillus anthracis protective antigen nucleic acid sequences

    The United States of America, as represented by the Department of Health and Human Services · Granted Oct 25, 2011 · Expires Oct 20, 2031

    granted

  7. US 8044187

    Human luteinizing hormone superagonists

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 25, 2011 · Expires Oct 20, 2031

    granted

  8. US 8039585

    Therapeutic administration of the scrambled anti-angiogenic peptide C16Y

    The United States of America, as represented by the Department of Health and Human Services · Granted Oct 18, 2011 · Expires Oct 13, 2031

    granted

  9. US 8039003

    Recombinant attenuated dengue viruses comprising a deletion in the 3′ untranslated region and additional attenuating mutations induced by chemical mutagenesis

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 18, 2011 · Expires Oct 13, 2031

    granted

  10. US 8039593

    Antibodies and immunotoxins that target human glycoprotein NMB

    The United States of America, as represented by the Secretary, Health and Human Services · Granted Oct 18, 2011 · Expires Oct 13, 2031

    granted

  11. US 8034334

    Immunotherapy with in vitro-selected antigen-specific lymphocytes after non-myeloablative lymphodepleting chemotherapy

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 11, 2011 · Expires Oct 6, 2031

    granted

  12. US 8030285

    Oligodeoxynucleotide and its use to induce an immune response

    The United States of America, as represented by the Department of Health and Human Services · Granted Oct 4, 2011 · Expires Sep 29, 2031

    granted

  13. US 8030280

    Melanoma antigens and their use in diagnostic and therapeutic methods

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 4, 2011 · Expires Sep 29, 2031

    granted

  14. US 8029809

    Bacteriocins and novel bacterial strains

    The United States of America, as represented by the Secretary of Agriculture · Granted Oct 4, 2011 · Expires Sep 29, 2031

    granted

  15. US 8022175

    Production of anti-peptide monoclonal antibodies to distinguish Exotic New Castle diseases viruses from vaccine strains of Newcastle disease virus

    The United States of America, as represented by the Secretary of Agriculture · Granted Sep 20, 2011 · Expires Sep 15, 2031

    granted

  16. US 8017130

    Method of accelerated vaccination against Ebola viruses

    The United States of America, as represented by the Department of Health and Human Services · Granted Sep 13, 2011 · Expires Sep 8, 2031

    granted

  17. US 8012730

    Specific lysis of staphylococcal pathogens by bacteriophage phi11 endolysin

    The United States of America, as represented by the Secretary of Agriculture · Granted Sep 6, 2011 · Expires Sep 1, 2031

    granted

  18. US 8008316

    Azonafide derived tumor and cancer targeting compounds

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 30, 2011 · Expires Aug 25, 2031

    granted

  19. US 8008266

    Methods of treating cancer using immunostimulatory oligonucleotides

    The United States of America, as represented by the Department of Health and Human Services · Granted Aug 30, 2011 · Expires Aug 25, 2031

    granted

  20. US 8003629

    21-substituted progesterone derivatives as new antiprogestational agents

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 23, 2011 · Expires Aug 18, 2031

    granted

  21. US 8003406

    Methods for detecting attention-deficit/hyperactivity disorder

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 23, 2011 · Expires Aug 18, 2031

    granted

  22. US 8003112

    Meningococcal and pneumococcal conjugate vaccine and method of using same

    THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, OFFICE OF TECHNOLOGY TRANSFER—NATIONAL INSTITUTES OF HEALTH · Granted Aug 23, 2011 · Expires Aug 18, 2031

    granted

  23. US 7999074

    Bacteriocins and novel bacterial strains

    The United States of America, as represented by the Secretary of Agriculture · Granted Aug 16, 2011 · Expires Aug 11, 2031

    granted

  24. US 7999071

    Human cytotoxic T-lymphoctye epitope and its agonist eptiope from the non-variable number of tandem repeat sequence of MUC-1

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 16, 2011 · Expires Aug 11, 2031

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.